| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CL1991B | 
                         | 
                    2805804-54-8 | 
                         CP-547632 TFA 98+%  | 
                    C20H24BrF2N5O3S·C2HF3O2 | |
| CL2879A | 
                         | 
                    210644-62-5 | 
                         (Z)-Orantinib | (Z)-SU6668 | (Z)-TSU-68 98+%  | 
                    C18H18N2O3 | |
| CL2509 | 
                         | 
                    1013920-15-4 | 
                         Vorolanib (X-82,CM082) 98+%  | 
                    C23H26FN5O3 | |
| CL2507A | 
                         | 
                    1218779-75-9 | 
                         Apatinib Mesylate 98+%  | 
                    C24H23N5O · CH4O3S | |
| CL2507 | 
                         | 
                    811803-05-1 | 
                         Apatinib | Apatinib Free base | YN968D1| Rivoceranib 98+%  | 
                    C24H23N5O | |
| CL2424 | 
                         | 
                    557795-19-4 | 
                         Sunitinib | Sunitinib Base 99+%  | 
                    C22H27FN4O2 | |
| CLA1508 | 
                         | 
                    1607793-29-2 | 
                         Anti-Human VEGFAxANGPT2 (Faricimab; RG7716) 95+%  | 
                    — | |
| CLA1267 | 
                         | 
                    1024603-92-6 | 
                         Icrucumab (Anti-VEGFR1 / FLT1) 95+%  | 
                    — | |
| CLA1179 | 
                         | 
                    934216-54-3 | 
                         Alacizumab (Anti-VEGFR2 / KDR / CD309) 95+%  | 
                    — | |
| CL2214 | 
                         | 
                    215543-92-3 | 
                         (Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid. 98+%  | 
                    C17H16N2O3 | |
| CL1631 | 
                         | 
                    288383-20-0 | 
                         Cediranib | ADZ-2171 | NSC-732208 98+%  | 
                    C25H27FN4O3 | |
| CL1633 | 
                         | 
                    417716-92-8 | 
                         Lenvatinib | E7080 98+%  | 
                    C21H19ClN4O4 | |
| CL1636 | 
                         | 
                    444731-52-6 | 
                         Pazopanib | GW786034 99+%  | 
                    C21H23N7O2S | |
| CL1637 | 
                         | 
                    319460-85-0 | 
                         Axitinib | AG-013736 98+%  | 
                    C22H18N4OS | |
| CLA1018 | 
                         | 
                    947687-13-0 | 
                         Ramucirumab; LY3009806; IMC-1121B 98+%  | 
                    — | |
| CLA1008 | 
                         | 
                    216974-75-3 | 
                         Bevacizumab (anti-VEGF) | RhuMab VEGF 95+%  | 
                    — | |
| CL1991 | 
                         | 
                    252003-65-9 | 
                         CP-547632 (Synonyms: PAN-90806; CP-632; OSI-632) 98+%  | 
                    C20H24BrF2N5O3S | |
| CL1906 | 
                         | 
                    212141-51-0 | 
                         Vatalanib Dihydrochloride | Vatalanib 2HCl 98+%  | 
                    C20H17Cl3N4 | |
| CL2094 | 
                         | 
                    453562-69-1 | 
                         Motesanib (Synonyms: AMG 706;莫替沙尼 ) 98+%  | 
                    C22H23N5O | |
| HL1306 | 
                         | 
                    568-72-9 | 
                         Tanshinone IIA | Dan Shen Ketone 98+%  | 
                    C19H18O3 | |